/PRNewswire/ The global pharmacovigilance and drug safety software market size is expected to grow by USD 72.74 million from 2021 to 2026, at a CAGR of.
Middle East and Africa Pharmacovigilance and Drug Safety globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Adverse Event Reporting Software Segment to Grow at Highest CAGR During 2020-2027
Pharmacovigilance and Drug Safety Software Market is expected to reach US$ 292.97 Mn in 2027 from US$ 160.67 Mn in 2019. The market is estimated to grow at a CAGR of 7.6% from 2020 to 2027.
The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance have been boosting the market over the years. However, the expensive technology is likely to have a negative impact on the growth of the market in the coming years.